Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sublingual Film for Dermatophagoides Pteronyssinus in Chinese Adult Patients With Dust Mite Allergic Rhinitis
NCT07475715Phase 2Not yet recruiting
- Sponsor
- Wolwo Biotech
- Start
- Mar 2026
- Primary completion
- Jun 2027
- Modality
- Allergy Immunotherapy
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of dermatophagoides pteronyssinus in allergic rhinitis (AR) (5 arms), sponsored by Wolwo Biotech. Primary endpoint: Daily combined scores of rhinitis symptoms and medication. Planned start Mar 2026; status: not yet recruiting.
02
Drugs
dermatophagoides pteronyssinus
03
Conditions
allergic rhinitis (AR)
Beyond the preview
Go deeper on NCT07475715.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07475715.